Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Nardi

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Drugs in Context|May 28, 2026
SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implicationsMario Manunta, Giacomo Matteo Bruno, Angelo Ferrantelli, et al.
The American Journal of Cardiology|June 24, 2026
Semaglutide for the Silent Phenotype: A Translational Signal in Obesity-Driven HFpEFRoberto Ceravolo, Fabiana Lucà, Michele Massimo Gulizia, et al.
Giornale Italiano Di Cardiologia (2006)|July 26, 2023
[Erectile dysfunction and cardiovascular risk]Danilo Baccino, Antonio Francesco Amico, Stefania Angela Di Fusco, et al.
Open Heart|September 19, 2024
Appropriate use of wearable defibrillators with multiparametric evaluation to avoid unnecessary defibrillator implantationAndrea Matteucci, Carlo Pignalberi, Stefania Di Fusco, et al.
Giornale Italiano Di Cardiologia (2006)|July 7, 2025
[Evolution of cardiovascular risk stratification]Andrea Matteucci, Stefania Angela Di Fusco, Alessandro Aiello, et al.
Journal of Clinical Lipidology|March 15, 2026
Comparative efficacy and safety of obicetrapib vs bempedoic acid on top of statin therapy: A network meta-analysisAndrea Matteucci, Stefania Angela Di Fusco, Michela Bonanni, et al.
Giornale Italiano Di Cardiologia (2006)|July 7, 2025
[Fixed-dose combination therapy with rosuvastatin/acetylsalicylic acid in the cardiovascular risk continuum]Stefania Angela Di Fusco, Andrea Matteucci, Antonella Spinelli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
Inclisiran safety and efficacy in real-world clinical practice: results of a retrospective observational investigationStefania Angela Di Fusco, Andrea Matteucci, Alessandro Aiello, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 29, 2026
Bempedoic acid for prevention of atherosclerotic cardiovascular disease: from trials to clinical practiceFurio Colivicchi, Stefania Angela Di Fusco, Marcello Arca, et al.
Reviews on Recent Clinical Trials|August 3, 2016
Ticagrelor: Long-Term Therapy in Patients with Coronary Artery DiseaseAndrea Rognoni, Chiara Cavallino, Alessandro Lupi, et al.
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Drugs in Context|May 28, 2026
SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implicationsMario Manunta, Giacomo Matteo Bruno, Angelo Ferrantelli, et al.
The American Journal of Cardiology|June 24, 2026
Semaglutide for the Silent Phenotype: A Translational Signal in Obesity-Driven HFpEFRoberto Ceravolo, Fabiana Lucà, Michele Massimo Gulizia, et al.
Giornale Italiano Di Cardiologia (2006)|July 26, 2023
[Erectile dysfunction and cardiovascular risk]Danilo Baccino, Antonio Francesco Amico, Stefania Angela Di Fusco, et al.
Open Heart|September 19, 2024
Appropriate use of wearable defibrillators with multiparametric evaluation to avoid unnecessary defibrillator implantationAndrea Matteucci, Carlo Pignalberi, Stefania Di Fusco, et al.
Giornale Italiano Di Cardiologia (2006)|July 7, 2025
[Evolution of cardiovascular risk stratification]Andrea Matteucci, Stefania Angela Di Fusco, Alessandro Aiello, et al.
Journal of Clinical Lipidology|March 15, 2026
Comparative efficacy and safety of obicetrapib vs bempedoic acid on top of statin therapy: A network meta-analysisAndrea Matteucci, Stefania Angela Di Fusco, Michela Bonanni, et al.
Giornale Italiano Di Cardiologia (2006)|July 7, 2025
[Fixed-dose combination therapy with rosuvastatin/acetylsalicylic acid in the cardiovascular risk continuum]Stefania Angela Di Fusco, Andrea Matteucci, Antonella Spinelli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 20, 2026
Inclisiran safety and efficacy in real-world clinical practice: results of a retrospective observational investigationStefania Angela Di Fusco, Andrea Matteucci, Alessandro Aiello, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 29, 2026
Bempedoic acid for prevention of atherosclerotic cardiovascular disease: from trials to clinical practiceFurio Colivicchi, Stefania Angela Di Fusco, Marcello Arca, et al.
Reviews on Recent Clinical Trials|August 3, 2016
Ticagrelor: Long-Term Therapy in Patients with Coronary Artery DiseaseAndrea Rognoni, Chiara Cavallino, Alessandro Lupi, et al.
Pageof 14